Robert Langreth

Drugstore are trying to keep Amazon from wresting away their piece of the $333 billion prescription-drug industry.

Pharmacy benefits managers lay out lobby plan in strategy memo as the middlemen are now taking it from all sides.

Nathan Schwegman was just 25 when his doctor told him he had a 3% chance of surviving the melanoma that had spread into his lungs and spine, soon leaving him in so much pain he could hardly move.

Merck & Co., Bristol-Myers Squibb Co. and Roche Holding AG have opened a new front against cancer with the next generation of experimental drugs that use the human immune system to seek and destroy tumor cells.